Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NF-kappaB in the pathogenesis and treatment of multiple myeloma.

Current opinion in hematology - 1 Jul 2008

Li Zhi-Wei, Chen Haiming, Campbell Richard A, Bonavida Benjamin, Berenson James R

Abstract excerpt

PURPOSE OF REVIEW: This review aims to summarize recent advances in the mechanisms through which the activation of the transcription factor NF-kappaB contributes to the pathogenesis of multiple myeloma. RECENT FINDINGS: This transcription factor regulates expression of numerous genes involved in multiple myeloma pathogenesis, including growth, survival, immortalization, angiogenesis and metastasis. Recently,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Multiple Myeloma
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to NF-kappa B p50 Subunit

Source

Identifiers

PMID: 18536579
DOI: 10.1097/MOH.0b013e328302c7f4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NF-kappaB in the pathogenesis and treatment of multiple myeloma.PMID 18536579Read ↗

Targeting NF-κB Signaling for Multiple MyelomaSemantic proximity Read ↗

Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.Semantic proximity Read ↗

Multiple myeloma: lusting for NF-kappaB.Semantic proximity Read ↗

Multiple myeloma.Semantic proximity Read ↗

Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple MyelomaSemantic proximity Read ↗

[Molecular pathogenesis of myeloma for the therapeutic targets].Semantic proximity Read ↗

Nuclear factor‐KappaB modulation as a therapeutic approach in hematologic malignanciesSemantic proximity Read ↗

Frequent Engagement of RelB Activation Is Critical for Cell Survival in Multiple MyelomaSemantic proximity Read ↗

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.Semantic proximity Read ↗

Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway.Semantic proximity Read ↗

Overcoming bortezomib resistance in multiple myelomaSemantic proximity Read ↗

Impact of Genetic Polymorphisms in NF-ĸB2 and TRAF3 Genes on Response to Bortezomib-Based Therapy in Multiple Myeloma Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.